227 Patient pre-selection outcomes for the European GENEGRAFT ex vivo phase I/II gene therapy trial for recessive dystrophic epidermolysis bullosa: ESDR 2017 Annual Meeting47th Annual ESDR Meeting

S.M. Lwin, S. Gaucher, M. Titeux, A. Abdul-Wahab, N. Pironon, S. Miskinyte, C. GANIER, S. Duchatelet, J. McGrath, A. Hovnanian

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)S231
JournalJournal of Investigative Dermatology
Issue number10, Supplement 2
Publication statusE-pub ahead of print - 8 Sept 2017

Cite this